 | Contact | Site Map | News | | Change Font Size | |  | |  |  |  |
Kytogenics Pharmaceuticals Inc.
|
kytogenics.com |
 |
Innovacorp is an investor in Kytogenics Pharmaceuticals Inc.
Kytogenics Pharmaceuticals Inc. is a research/product development manufacturing company which produces N,O-carboxymethylchitosan, a platform polymer technology based on a natural polysaccharide. Kytogenics Pharmaceuticals Inc. has developed several innovative applications of NOCC and its derivatives in the medical area. The company's lead product will soon enter clinical trials. NOCC technology is protected by five patents with more pending.
Products and Services
- Medical applications: surgical aids to reduce adhesions, wound healing, and drug delivery device
- Veterinary application: drug delivery agent
- Food applications: preservative coating to extend storage of fruits and vegetables and pheromone delivery systems for insect control
- Sonar applications: sonar transmission fluid
- Cosmetic applications: moisturizer, texturizer, gel base, and adhesive
Email this page
The Early Stage Commercialization Fund (ESCF) assists the academic community in the pursuit of commercialization opportunities.
Learn More +